Table 7.
Placebo (n = 48) |
OnabotA 240 U (n = 52) |
OnabotA 360 U (n = 55) |
p-Values OnabotA 240 U vs. Placebo |
p-Values OnabotA 360 U vs. Placebo |
|
---|---|---|---|---|---|
Baseline | 2.65 | 2.34 * | 2.44 | 0.035 | 0.151 |
Week 1 | −0.28 | −0.58 * | −0.61 * | 0.005 | 0.011 |
Week 6 | −0.39 | −0.72 * | −0.93 * | 0.010 | <0.001 |
Week 12 | −0.23 | −0.50 * | −0.43 | 0.009 | 0.079 |
Week 18 | −0.37 | −0.60 * | −0.79 * | 0.048 | 0.001 |
Week 24 | −0.46 | −0.53 | −0.59 | 0.498 | 0.230 |
Week 30 | −0.30 | −0.45 | −0.35 | 0.151 | 0.645 |
* p-value ≤ 0.05 for onabotA vs. placebo.a Upper arm score was the aggregate of average scores across all upper limb muscles (i.e., elbow, wrist, fingers, and thumb).